Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anawah, Inc. was a Seattle-based agricultural biotechnology company that specialized in advanced plant breeding and functional genomics. Founded in 2000 as a spinout from the Fred Hutchinson Cancer Research Center, the company utilized its proprietary TILLING (Targeting Induced Local Lesions In Genomes) technology to identify and exploit natural genetic variation in crops. This approach allowed for the development of improved plant varieties with enhanced nutritional profiles and longer shelf-lives without the use of genetic engineering (non-GMO). Anawah's research programs targeted high-value whole foods such as tomatoes, lettuce, and wheat, aiming to provide consumers with more nutritious and better-tasting produce. The company was acquired by Arcadia Biosciences in 2005 to integrate its non-GMO breeding platform into Arcadia's broader agricultural portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anawah.